Company news
Tci Gene Inc. news
Latest news releases, newest first.
Board of Directors' Resolution for the change of the accounting officer (Supplementary)
July 21, 2022
Board of Directors' Resolution for the change of the accounting officer
July 20, 2022
Tci Gene: Board of Directors approved the financial reports for the second quarter of 2022
July 20, 2022
Announcement of the Company's Dividend Dstribution Rate Adjustment
July 15, 2022
Announcement of matters relating to the Ex-dividend Record Date of the Company
July 15, 2022
Update the contents of 2021 annual report
July 14, 2022
Monthly revenue report, June 2022
July 7, 2022
Tci Gene: Important resolutions of 2022 Annual General Shareholders' Meeting
June 30, 2022
Approve the lifting of non competition restrictions for directors and representatives in 2022 Annual General Shareholders Meeting's resolution
June 30, 2022
Announcement of Annual General Shareholders' Meeting by-election for a director
June 30, 2022
Monthly revenue report, May 2022
June 6, 2022
Announcement of the fully paid-in payment and record date of the Company's private placement common shares
May 25, 2022
Supplementary announcement of 2022/05/20 Board of Directors resolved on private placement counterparties and related matters
May 23, 2022
Board of Directors resolved on the price determination of private placement common shares and related matters
May 20, 2022
Board of Directors resolved to add new motions to the 2022 Annual General Shareholders Meeting
April 22, 2022
Tci Gene: Approved as regulations of Initial Public Offering (IPO), proposed to allow the original shareholders not to subscription the Rights Issue before the IPO new Issue.
April 22, 2022
Announcement of dividend distribution approved by Board of Directors
April 22, 2022
TCI GENE To announce the resignation of the company's institutional director
April 13, 2022
Board of Directors' Resolution for the change of the General Manager
March 22, 2022
Approve the lifting of non competition restrictions for newly General Manager
March 22, 2022
Announcement of the first Nominating Committee establishment and approved by the Company's board of directors.
March 22, 2022
Correction the information of "The basis and reasonableness of the private placement pricing" on M.O.P.S.
March 17, 2022
Board of directors newly elected chairman
March 17, 2022
Announcement the members of 2nd term of Compensation Committee
March 17, 2022
Announcement of the 1st term of Audit Committee and the list of name
March 17, 2022